New Delhi: Fermenta Biotech Restricted (FBL), an lively participant within the discipline of Lively Pharmaceutical Components (API), has introduced that its Dahej manufacturing facility in Gujarat, India, has been awarded the distinguished European Union Good Manufacturing Apply (EU GMP) certification.
The certification, granted by the Competent Authority of Germany, follows a profitable inspection carried out in March 2024.
Commenting on the achievement, Prashant Nagre, Managing Director of Fermenta Biotech, stated, “We’re happy with the optimistic end result of the latest EU GMP inspection at our Dahej Manufacturing Facility in Gujarat. The certificates of GMP compliance underscores our dedication to world requirements of high quality, compliance, and consistency in manufacturing.”
The EU GMP certification is a necessary requirement for pharmaceutical firms aiming to produce merchandise within the European Union, assuring that manufacturing practices meet the stringent high quality pointers laid out by the European Medicines Company (EMA).
With this newest certification, the corporate is well-positioned to increase its attain in regulated markets, delivering high-quality merchandise that meet worldwide benchmarks.
The put up Fermenta Biotech’s Dahej manufacturing facility secures EU GMP certification appeared first on BioVoiceNews.